Every recall we track for Nephron Sterile Compounding Center LLC — 73 in all — plus the complaints and injury reports the public filed about them.
Nephron recalls 500mL Sodium Chloride Injection 9% IV bottles due to potential leakage at the IV port. This could lead to contamination risks during medical use. Affected lots and expiration dates listed.
Nephron recalls phenylephrine injections due to lack of sterility assurance. Products may cause infections if used improperly. Check NDC 69374-301-10 and lot numbers PE2029.
Nephron Sterile Compounding Center recalls norepinephrine injection with potential contamination risk. Products from specific lots and expiration dates may be unsafe for medical use.
Nephron Sterile Compounding Center recalls norepinephrine injection with potential lack of sterility. Affected lots expire through March 2024. Consumers should contact manufacturer for details.
Nephron recalls phenylephrine injection vials due to lack of sterility assurance. This could lead to infections if used improperly. Check your product details to see if you have affected items.
Nephron recalls specific diltiazem injection bottles due to lack of sterility assurance. This affects certain 125mL single-dose containers with NDC 69374-997-15. Patients should contact their healthcare provider for safe alternatives.
Nephron recalls phenylephrine HCl injection due to lack of sterility assurance. This product poses a risk of infection if used. Affected lots: PS2008A, expiring 03/07/2023.
Nephron recalls phenylephrine injections with possible contamination. Products may cause infection if used. Check lot numbers on packaging for affected batches.
Nephron recalls specific norepinephrine injections due to lack of sterility assurance. Affected lots expire by 2023-07-27. Contact for details.
Nephron recalls specific Rocuronium Bromide injection vials due to potential lack of sterility, which could cause infections if used. Affected products include 50 mg/5 mL syringes with lot RC2011A.
Nephron recalls specific labetalol injection vials due to potential cross contamination from product carry over during manufacturing. This is for prescription use only.
Nephron recalls PF-Neostigmine Methylsulfate Injection vials due to potential cross contamination from product carry over. Affected lots expire by December 2022. Contact for remedy.
Nephron recalls Trisodium Citrate 0.5% Solution (0.5%/4L) due to potential cross-contamination during manufacturing. This product is prescription-only and may be found in specific lots.
Nephron recalls specific bupivacaine injections due to potential cross-contamination during manufacturing. Affected lots have NDC 69374-970-05 and expire by 8/19/2022 or 11/9/2022.
Nephron recalls 30-unit vial of PF-Labetalol HCl Injection due to potential cross-contamination during manufacturing. This medication is for prescription use only.
Nephron recalls PF-Neostigmine Methylsulfate Injection vials due to potential cross-contamination during manufacturing. This medication is prescription-only and may be affected by lot NE1057A.
Nephron recalls Neostigmine Methylsulfate injections due to potential lack of sterility. This could cause infections if used. Patients should contact their healthcare provider for guidance.
Nephron recalls 0.9% buffered lidocaine syringes due to lack of sterility assurance. Affected units were manufactured in 2007 and expire July 2022. Consumers should contact Nephron for details.
Nephron recalls Ketamine HCl injection with potential lack of sterility. Affected lots expire by 2022-10-18. Consumers should check NDC numbers and lot codes for affected products.
Nephron recalls EPINEPHrine injection syringes due to lack of sterility assurance. Products may cause infections if used. Check NDC codes and expiration dates for affected lots.
Nephron recalls Oxytocin 30 Units/500 mL IV bags due to lack of sterility assurance. Affected lots expire 7/9/2022. Contact for return instructions.
Nephron recalls epinephrine syringes due to lack of sterility assurance. These pre-filled syringes may cause infections if used. Check NDC 69374-544-10 and expiration dates for affected lots.
Nephron recalls 1000mL Cardioplegia Solution IV bags with potential contamination. These are prescription-only products used in cardiac surgery. Contact Nephron for details on affected lots and remedies.
Nephron recalls phenylephrine injections due to lack of sterility assurance. Products may cause infections if used improperly. Check NDC 69374-956-10 for affected lots.
Nephron recalls 50 mL pre-filled bupivacaine syringes due to lack of sterility assurance. These syringes may cause infections if used for medical procedures.
Nephron Sterile Compounding Center recalls 50 mg hydro morphine syringes due to lack of sterility assurance. Affected units may cause infection if used.
Nephron recalls morphine syringes due to potential contamination. Affected units have specific NDC and expiration dates. Consumers should contact Nephron for details.
Nephron recalls Atropine Sulfate Injection syringes due to lack of sterility assurance. This could lead to infections if used improperly. Check NDC codes and expiration dates for affected lots.
Nephron recalls Morphine Sulfate Injection syringes due to lack of sterility assurance. Products may cause infections if used improperly. Check NDC codes and expiration dates for affected lots.
Nephron recalls Neostigmine Methylsulfate Injection due to lack of sterility assurance. This medication is for prescription use only and may cause infections if used improperly.
Nephron recalls Rocuronium Bromide Injection (50 mg/5mL) due to lack of sterility assurance. This could lead to infections if used improperly. Affected products have specific NDC and lot numbers.
Nephron recalls phenylephrine injections with potential sterility issues. Affected lots expire by 2023; check your NDC number for recall.
Nephron recalls Morphine Sulfate Injection 1 mg/mL syringes due to lack of sterility assurance. This could lead to infections if used improperly. Check your NDC number for affected lots.
Nephron recalls sterile amino acid injection bags (NDC 69374-988-10) due to lack of sterility assurance. Patients may face infection risks from contaminated products.
Nephron recalls phenylephrine injections due to lack of sterility assurance. Affected lots expire through 2022. Consumers should contact Nephron for details.
Nephron recalls Neostigmine Methylsulfate injections due to lack of sterility assurance. This affects specific lots and expiration dates. Patients should contact their healthcare provider for guidance.
Nephron recalls sterile glycopyrrolate injection vials due to lack of assurance of sterility. This could lead to infections if used improperly. Check your medication labels for NDC 69374-903-30 and lot GL2004A.
Nephron recalls 50 mg/5 mL Ketamine syringes due to lack of sterility assurance. Affected lots expire 7/20/2022. Stop using immediately to avoid infection risks.
Nephron recalls specific injections due to lack of sterility assurance. Products may cause infections if used. Stop using and contact for details.
Nephron recalls sterile injections with potential contamination risk. Products may cause infection if used. Contact for details.
Nephron recalls sterile succinylcholine chloride injection due to lack of assurance of sterility. This medication is for medical use only and may cause infections if not properly sterilized.
Nephron recalls 50 mL hydromorphone injections with potential sterility issues. Affected lots may cause infections if used.
Nephron recalls 5x5mL glycopyrrolate injections due to lack of sterility assurance. This could cause infections if used improperly. Check NDC 69374-903-05 and lot GL2002B.
Nephron recalls 5x5mL pre-filled succinylcholine syringes due to lack of sterility assurance. These injections are for medical use only and should not be used if they may cause infection.
Nephron recalls phenylephrine injections with possible contamination. Stop using if you have the specific lot numbers listed. This is for medical use only.
Nephron recalls phenylephrine injections with potential sterility issues. Affected lots expire by May 2022. Stop using if you have these syringes.
Nephron recalls oxytocin IV bags due to lack of sterility assurance. These bags may contain contaminants and should not be used for medical treatment.
Nephron recalls 150mL Fentanyl IV bags with potential sterility issues. Affected lots expired by June 2022. Stop using immediately if you have these bags.
